Cladis Investment Advisory, LLC Amgen Inc Transaction History

Cladis Investment Advisory, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 09, 2024	SELL	$262.75 - $319.31 $685,777 - $833,399	-2,610 Reduced 76.76%	790 $247 Million
Q1 2024 Oct 09, 2024	BUY	$268.87 - $324.56 $914,158 - $1.1 Million	3,400 New	3,400 $225 Million
Q3 2023 Oct 09, 2024	BUY	$218.65 - $271.46 $183,666 - $228,026	840 New	840 $226 Million
Q2 2023 Oct 09, 2024	SELL	$214.27 - $253.37 $21,427 - $25,337	-100 Reduced 9.17%	990 $220 Million
Q1 2023 Oct 09, 2024	BUY	$225.79 - $275.2 $246,111 - $299,968	1,090 New	1,090 $264 Million
Q4 2022 Oct 09, 2024	SELL	$229.03 - $291.01 $154,595 - $196,431	-675 Reduced 38.24%	1,090 $286 Million
Q3 2022 Oct 09, 2024	BUY	$224.46 - $253.15 $396,171 - $446,809	1,765 New	1,765 $398 Million
Q3 2022 Nov 17, 2022	SELL	$224.46 - $253.15 $89,784 - $101,260	-400 Reduced 24.02%	1,265 $285,000
Q2 2022 Oct 09, 2024	BUY	$230.71 - $256.74 $499,487 - $555,842	2,165 New	2,165 $527 Million
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $471,801 - $525,033	-2,045 Reduced 55.12%	1,665 $405,000
Q1 2022 Oct 08, 2024	SELL	$219.27 - $242.57 $241,197 - $266,827	-1,100 Reduced 22.87%	3,710 $897 Million
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $131,562 - $145,542	-600 Reduced 13.92%	3,710 $897,000
Q4 2021 Oct 08, 2024	BUY	$198.88 - $227.6 $956,612 - $1.09 Million	4,810 New	4,810 $1.08 Billion
Q4 2021 Oct 01, 2024	BUY	$198.88 - $227.6 $857,172 - $980,956	4,310 New	4,310 $970 Million
Q4 2021 May 10, 2022	BUY	$198.88 - $227.6 $857,172 - $980,956	4,310 New	4,310 $970,000

3,121

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Cladis Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Cladis Investment Advisory, LLC with notifications on news.